<p>, /PRNewswire/ -- SelectQuote Inc. <strong>(NYSE: SLQT)</strong>，一家以銷售醫療保險優勢計劃而聞名的數字保險平台，正面臨美國司法部（DOJ）介入的舉報者訴訟的高度法律審查，該訴訟指控其存在欺騙性銷售行為。聯邦行動導致 SelectQuote 的股價在 2025 年 5 月 1 日急劇下跌 19%，並已導致代表投資者提起的證券集體訴訟。</p>
<p>該訴訟，<em>Pahlkotter 訴 SelectQuote Inc.等</em>，涵蓋了在 2020 年 9 月 9 日至 2025 年 5 月 1 日期間購買 SelectQuote 股票的投資者，並指控該公司誤導市場關於其商業模式和監管風險。</p>
<p>Hagens Berman 敦促 SelectQuote 的投資者，如果遭受重大損失，請立即提交您的損失。</p>
<p>** 集體訴訟期間：**2020 年 9 月 9 日–2025 年 5 月 1 日</p>
<p>** 主要原告截止日期：**2025 年 10 月 10 日</p>
<p><strong>訪問：</strong> www.hbsslaw.com/investor-fraud/slqt</p>
<p><strong>立即聯繫該公司：</strong>[email protected]</p>
<p><strong>844-916-0895</strong></p>
<p><strong>回扣和虛假陳述的指控</strong></p>
<p>投訴的核心是 SelectQuote 虛假陳述其醫療保險優勢銷售行為。儘管該公司公開宣傳其服務提供 “公正的建議” 和 “中立的計劃比較”，但訴訟聲稱 SelectQuote：</p>
<ul>
<li>將客户引導至提供最高佣金的保險公司計劃。</li>
<li>接受非法回扣以換取優待。</li>
<li>違反聯邦法規，包括虛假索賠法。</li>
</ul>
<p>司法部的投訴指控，從 2016 年至至少 2021 年，SelectQuote 收到了數千萬美元的不當支付，並通過將客户引導遠離低利潤計劃而歧視了利潤較低的客户。</p>
<p><strong>市場影響和投資者影響</strong></p>
<p>司法部的介入在市場上引發了震盪，SelectQuote 的股票在一天內暴跌近 20%。在過去六個月中，股價下降超過 40%，反映出投資者對該公司法律風險和潛在聲譽損害的擔憂。</p>
<p>集體訴訟認為，SelectQuote 的公開聲明未能披露與其銷售行為相關的重大風險，導致投資者高估了公司的增長前景和收入完整性。</p>
<p><strong>Hagens Berman 調查涉嫌收入操控</strong></p>
<p>股東權益公司 Hagens Berman 正在調查 SelectQuote 的收入是否通過欺騙行為被人為抬高。該公司的合夥人 Reed Kathrein 評論道：“司法部的介入將此事從常規商業爭議轉變為嚴重的聯邦問題。我們正在審查 SelectQuote 所謂的 ‘公正’ 模型是否僅僅是一個以回扣驅動的銷售引擎的幌子。”</p>
<p>如果您投資了 SelectQuote 並遭受重大損失，或有可能協助該公司調查的信息，請立即提交您的損失 »</p>
<p>如果您想了解更多信息以及關於 SelectQuote 案件和我們調查的常見問題的答案，請閲讀更多 »</p>
<p><strong>舉報者：</strong> 瞭解 SelectQuote 非公開信息的人員應考慮其選項，以幫助調查或利用 SEC 舉報者計劃。在新計劃下，提供原始信息的舉報者可能會獲得高達 SEC 成功追回金額 30% 的獎勵。有關更多信息，請致電 Reed Kathrein，電話為 <strong>844-916-0895</strong> 或發送電子郵件至 [email protected]。</p>
<p>關於 Hagens Berman</p>
<p>Hagens Berman 是一家全球性的原告權益複雜訴訟公司，專注於企業問責。該公司擁有強大的業務，代表投資者以及舉報者、工人、消費者和其他在因企業疏忽和其他不當行為而受到傷害的案件中取得實際結果。Hagens Berman 的團隊在該法律領域已獲得超過 29 億美元的賠償。有關該公司及其成功的更多信息，請訪問 hbsslaw.com。關注該公司以獲取更新和新聞，推特賬號為 @ClassActionLaw。</p>
<p>來源 Hagens Berman Sobol Shapiro LLP</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwOTI1Jk5ld3NJdGVtSWQ9U0Y4Mzc1NCZUcmFuc21pc3Npb25fSWQ9MjAyNTA5MjUxNjMzUFJfTkVXU19VU1BSX19fX19TRjgzNzU0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwOTI1Jk5ld3NJdGVtSWQ9U0Y4Mzc1NCZUcmFuc21pc3Npb25fSWQ9MjAyNTA5MjUxNjMzUFJfTkVXU19VU1BSX19fX19TRjgzNzU0"/></p>

SLQT

<p>SelectQuote Inc.（紐約證券交易所代碼：SLQT）正面臨一起證券集體訴訟，此案源於美國司法部（DOJ）介入的一起舉報者案件，指控其在與醫療保險優勢計劃相關的銷售中存在欺詐行為。訴訟稱，SelectQuote 誤導投資者關於其商業模式和監管風險的信息，導致其股價在 2025 年 5 月 1 日下跌 19%。指控包括引導客户選擇高佣金計劃和接受非法回扣。律師事務所 Hagens Berman 正在調查潛在的收入操控，並鼓勵受影響的投資者站出來</p>

<p>, /PRNewswire/ -- SelectQuote Inc. <strong>(NYSE: SLQT)</strong>, a digital insurance platform known for selling Medicare Advantage plans, is facing heightened legal scrutiny after the U.S. Department of Justice (DOJ) intervened in a whistleblower lawsuit alleging deceptive sales practices. The federal action triggered a sharp 19% drop in SelectQuote's share price on May 1, 2025, and has now led to a securities class-action lawsuit filed on behalf of investors.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- SelectQuote Inc. <strong>(NYSE: SLQT)</strong>，一家以銷售醫療保險優勢計劃而聞名的數字保險平台，正面臨美國司法部（DOJ）介入的舉報者訴訟的高度法律審查，該訴訟指控其存在欺騙性銷售行為。聯邦行動導致 SelectQuote 的股價在 2025 年 5 月 1 日急劇下跌 19%，並已導致代表投資者提起的證券集體訴訟。</p>
</div><p>The suit, <em>Pahlkotter v. SelectQuote Inc. et al</em>., covers investors who purchased SelectQuote stock between September 9, 2020, and May 1, 2025, and alleges that the company misled the market about its business model and regulatory exposure.</p>
<div class="lb-trans"><p>該訴訟，<em>Pahlkotter 訴 SelectQuote Inc.等</em>，涵蓋了在 2020 年 9 月 9 日至 2025 年 5 月 1 日期間購買 SelectQuote 股票的投資者，並指控該公司誤導市場關於其商業模式和監管風險。</p>
</div><p>Hagens Berman urges SelectQuote investors who suffered substantial losses to submit your losses now.</p>
<div class="lb-trans"><p>Hagens Berman 敦促 SelectQuote 的投資者，如果遭受重大損失，請立即提交您的損失。</p>
</div><p><strong>Class Period:</strong> Sept. 9, 2020 – May 1, 2025</p>
<div class="lb-trans"><p>** 集體訴訟期間：**2020 年 9 月 9 日–2025 年 5 月 1 日</p>
</div><p><strong>Lead Plaintiff Deadline:</strong> Oct. 10, 2025</p>
<div class="lb-trans"><p>** 主要原告截止日期：**2025 年 10 月 10 日</p>
</div><p><strong>Visit:</strong> www.hbsslaw.com/investor-fraud/slqt</p>
<div class="lb-trans"><p><strong>訪問：</strong> www.hbsslaw.com/investor-fraud/slqt</p>
</div><p><strong>Contact the Firm Now:</strong>[email protected]</p>
<div class="lb-trans"><p><strong>立即聯繫該公司：</strong>[email protected]</p>
</div><p><strong>844-916-0895</strong></p>
<div class="lb-trans"><p><strong>844-916-0895</strong></p>
</div><p><strong>Allegations of Kickbacks and Misrepresentation</strong></p>
<div class="lb-trans"><p><strong>回扣和虛假陳述的指控</strong></p>
</div><p>At the heart of the complaint are claims that SelectQuote misrepresented its Medicare Advantage sales practices. While the company publicly promoted its services as offering &#34;unbiased advice&#34; and &#34;neutral plan comparisons,&#34; the lawsuit asserts that SelectQuote:</p>
<div class="lb-trans"><p>投訴的核心是 SelectQuote 虛假陳述其醫療保險優勢銷售行為。儘管該公司公開宣傳其服務提供 “公正的建議” 和 “中立的計劃比較”，但訴訟聲稱 SelectQuote：</p>
</div><ul>
<li>Steered customers toward plans from insurers offering the highest commissions.</li>
<li>Accepted illegal kickbacks in exchange for preferential treatment.</li>
<li>Violated federal statutes, including the False Claims Act</li>
</ul>
<div class="lb-trans"><ul>
<li>將客户引導至提供最高佣金的保險公司計劃。</li>
<li>接受非法回扣以換取優待。</li>
<li>違反聯邦法規，包括虛假索賠法。</li>
</ul>
</div><p>The DOJ's complaint alleges that from 2016 through at least 2021, SelectQuote received tens of millions of dollars in improper payments and discriminated against less profitable customers by directing them away from lower-margin plans.</p>
<div class="lb-trans"><p>司法部的投訴指控，從 2016 年至至少 2021 年，SelectQuote 收到了數千萬美元的不當支付，並通過將客户引導遠離低利潤計劃而歧視了利潤較低的客户。</p>
</div><p><strong>Market Fallout and Investor Impact</strong></p>
<div class="lb-trans"><p><strong>市場影響和投資者影響</strong></p>
</div><p>The DOJ's involvement sent shockwaves through the market, with SelectQuote's stock plunging nearly 20% in a single day. Over the past six months, shares have declined more than 40%, reflecting investor concern over the company's legal exposure and potential reputational damage.</p>
<div class="lb-trans"><p>司法部的介入在市場上引發了震盪，SelectQuote 的股票在一天內暴跌近 20%。在過去六個月中，股價下降超過 40%，反映出投資者對該公司法律風險和潛在聲譽損害的擔憂。</p>
</div><p>The class-action lawsuit argues that SelectQuote's public statements failed to disclose material risks tied to its sales practices, leading investors to overvalue the company's growth prospects and revenue integrity.</p>
<div class="lb-trans"><p>集體訴訟認為，SelectQuote 的公開聲明未能披露與其銷售行為相關的重大風險，導致投資者高估了公司的增長前景和收入完整性。</p>
</div><p><strong>Hagens Berman Investigates Alleged Revenue Manipulation</strong></p>
<div class="lb-trans"><p><strong>Hagens Berman 調查涉嫌收入操控</strong></p>
</div><p>Shareholder rights firm Hagens Berman is investigating whether SelectQuote's revenue was artificially inflated through deceptive conduct. Reed Kathrein, a partner at the firm, commented: &#34;The DOJ's intervention transforms this from a routine business dispute into a serious federal matter. We're examining whether SelectQuote's so-called 'unbiased' model was merely a façade for a kickback-driven sales engine.&#34;</p>
<div class="lb-trans"><p>股東權益公司 Hagens Berman 正在調查 SelectQuote 的收入是否通過欺騙行為被人為抬高。該公司的合夥人 Reed Kathrein 評論道：“司法部的介入將此事從常規商業爭議轉變為嚴重的聯邦問題。我們正在審查 SelectQuote 所謂的 ‘公正’ 模型是否僅僅是一個以回扣驅動的銷售引擎的幌子。”</p>
</div><p>If you invested in SelectQuote and have substantial losses, or have knowledge that may assist the firm's investigation, submit your losses now »</p>
<div class="lb-trans"><p>如果您投資了 SelectQuote 並遭受重大損失，或有可能協助該公司調查的信息，請立即提交您的損失 »</p>
</div><p>If you'd like more information and answers to frequently asked questions about the SelectQuote case and our investigation, read more »</p>
<div class="lb-trans"><p>如果您想了解更多信息以及關於 SelectQuote 案件和我們調查的常見問題的答案，請閲讀更多 »</p>
</div><p><strong>Whistleblowers:</strong> Persons with non-public information regarding SelectQuote should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at <strong>844-916-0895</strong> or email [email protected].</p>
<div class="lb-trans"><p><strong>舉報者：</strong> 瞭解 SelectQuote 非公開信息的人員應考慮其選項，以幫助調查或利用 SEC 舉報者計劃。在新計劃下，提供原始信息的舉報者可能會獲得高達 SEC 成功追回金額 30% 的獎勵。有關更多信息，請致電 Reed Kathrein，電話為 <strong>844-916-0895</strong> 或發送電子郵件至 [email protected]。</p>
</div><p>About Hagens Berman</p>
<div class="lb-trans"><p>關於 Hagens Berman</p>
</div><p>Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.</p>
<div class="lb-trans"><p>Hagens Berman 是一家全球性的原告權益複雜訴訟公司，專注於企業問責。該公司擁有強大的業務，代表投資者以及舉報者、工人、消費者和其他在因企業疏忽和其他不當行為而受到傷害的案件中取得實際結果。Hagens Berman 的團隊在該法律領域已獲得超過 29 億美元的賠償。有關該公司及其成功的更多信息，請訪問 hbsslaw.com。關注該公司以獲取更新和新聞，推特賬號為 @ClassActionLaw。</p>
</div><p>SOURCE Hagens Berman Sobol Shapiro LLP</p>
<div class="lb-trans"><p>來源 Hagens Berman Sobol Shapiro LLP</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwOTI1Jk5ld3NJdGVtSWQ9U0Y4Mzc1NCZUcmFuc21pc3Npb25fSWQ9MjAyNTA5MjUxNjMzUFJfTkVXU19VU1BSX19fX19TRjgzNzU0" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=SF83754&amp;Transmission_Id=202509251633PR_NEWS_USPR_____SF83754&amp;DateId=20250925"/></p>

Selectquote (SLQT) 在美國司法部介入醫療保險銷售調查後面臨投資者訴訟 - Hagens Berman